EGFR and non-small cell lung carcinoma: SNVs analysis showed that EGFR had a significantly higher mutation frequency in CSF, followed by the LSLT-BM, LSLT-noBM, and ESLT group, which might be contributed by a higher incidence of BMs for patients with EGFR mutation NSCLC [16].